Wire Stories
590RPT Realty Announces Acquisition of Mary Brickell Village in Miami, FL
Acquired Mary Brickell Village, a generational, grocery-anchored, mixed-use center in the premier financial district of Miami, for $216 million. Compelling value-creation opportunity...
- 528
Ceridian Reports Second Quarter 2022 Results
Dayforce recurring revenue up 29.0% year-over-year, or 30.7% on a constant currency basis3 Revenue of $301.2 million, up 20.3% year-over-year, or 22.7%...
- 511
RPT Realty Reports Second Quarter 2022 Results
Financial Highlights Net income attributable to common shareholders for the second quarter 2022 of $5.1 million, or $0.06 per diluted share, compared...
- 515
Wayside Technology Group Reports Second Quarter 2022 Results
Net Income Up 56% to $2.8 Million or $0.63 per Share, with Adjusted EBITDA (non-GAAP) up 27% to $4.5 Million Fifth Consecutive...
- 523
Quanergy Announces World’s First 2D 360° PoE LiDAR Sensor
IoT sensor reduces cost, increases detection accuracy for physical security and industrial uses SUNNYVALE, Calif.–(BUSINESS WIRE)–Quanergy Systems, Inc., (NYSE: QNGY) (“Quanergy”) a...
- 464
Global Pharmacy Benefit Management Market Report 2022-2027: Gaps in Information and Care & Prevalence of Fraud, Waste, and Abuse in the Healthcare Industry Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Pharmacy Benefit Management Market (2022-2027) by Service, Business Model, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with...
- 579
Dark Fiber Market Intelligence Report – Global Forecast to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dark Fiber Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Dark...
- 546
China-US Research: Common Good Must Triumph Over Mutual Suspicion, Says New Report
Findings show the global importance of China-US research collaboration and the value of international university networks HONG KONG–(BUSINESS WIRE)–#HigherEducation–Competition between China and...
- 589
ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial
SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that...
- 618
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
SEOUL, South Korea & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#Gout–LG Chem recently announced that the Company has submitted an IND application to the US FDA...
